Seattle, WA
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.
vilyatx.comThese are collections Vilya is a part of. Click on the collection name to view similar companies.
Series A
$21,000,000
Series A
$50,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Vilya.